| Literature DB >> 36246089 |
Daniel N Guerero1, Angus Bruce2, Sushanth Vayalapra1, Vishnu Menon2, Mohammed El Hadi2, Shehab Khashaba3.
Abstract
Background The European Association of Urology (EAU) recommends that the operative steps and documentation necessary for successful and appropriate management of bladder cancer include identifying factors necessary to assign disease risk stratification, clinical stage, adequacy of resection and the presence of complications and immediate intravesical chemotherapy administration. Aim To assess and improve the adequacy of current transurethral resection of bladder tumour (TURBT) documentation at a district general hospital in the UK against the EAU 2022 guidelines. Methods Operative notes over a one-year period were assessed for the inclusion of key steps to achieve a comprehensive TURBT as outlined by EAU guidelines. Outcomes included documentation on the details of the operative findings and intervention as well as the perioperative assessment. A standardised template for TURBT procedures was created and surgical staff received training on its usage. The audit was subsequently repeated after six months to assess for improvements. Results TURBT documentation of 78 cases in the first cycle was compared to 37 cases from the second cycle. Significant improvements in the documentation of tumour size (46% to 89%; p<0.05), tumour description (59% to 89%; p <0.05), depth of resection (36% to 89%; p<0.05), administration of chemotherapy (21% to 46%; p<0.05) and assessment for perforation (22% to 68%; p=0.001) were demonstrated. Improvements in pre-operative and post-operative examination rates under anaesthesia also achieved statistical significance (47% & 14% respectively to 89%; p<0.05). There was an increase in the documentation of completeness of resection but this did not achieve statistical significance (59% to 68%; p=0.42). Conclusion The operative note template led to the improvement in the documentation, improving the risk stratification of bladder cancer in patients undergoing TURBT. The use of procedure-specific operative note templates should be adopted for all commonly performed procedures to improve the completeness of documentation.Entities:
Keywords: clinical documentation improvement; guideline; non-muscle invasive bladder cancer; operation note; turbt
Year: 2022 PMID: 36246089 PMCID: PMC9550198 DOI: 10.7759/cureus.30131
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1The TURBT Operative Note Template
Demographic details of the patients included in the study.
| Case Details | Cycle 1 Documented n (%) | Cycle 2 Documented n (%) |
| Patient Age | 72 (41-90) | 67 (31-89) |
| Male | 59 (76%) | 29 (78%) |
| Female | 19 (24%) | 8 (22%) |
| Consultant Notes | 19 (24%) | 23 (62%) |
| Registrar Notes | 59 (76%) | 14 (38%) |
Number of tumours reported in each cycle.
| Number of Tumours | Cycle 1 n (%) | Cycle 2 n (%) |
| 1 | 52 (67%) | 26 (70%) |
| 2 | 11 (14%) | 2 (5%) |
| 3 | 2 (3%) | 1 (3%) |
| 4 | 2 (3%) | 1 (3%) |
| 5-10 | 3 (4%) | 0 (0%) |
| Multiple (10+) | 8 (10%) | 7 (19%) |
Tumour sizes reported in each cycle.
| Tumour Size/cm | Cycle 1 n (%) | Cycle 2 n (%) |
| <1cm | 10 (13%) | 8 (22%) |
| 1-2cm | 13 (17%) | 12 (32%) |
| 2-3cm | 10 (13%) | 7 (19%) |
| 3-4cm | 1 (1%) | 3 (8%) |
| 5cm | 2 (3%) | 3 (8%) |
| Undocumented | 42 (54%) | 4 (11%) |
Tumour characteristics reported in each cycle.
| Tumour Descriptor | Cycle 1 n=78 (%) | Cycle 2 n=37 (%) |
| Solid | 10 (13%) | 10 (27%) |
| Papillary | 23 (30%) | 18 (49%) |
| Superficial | 8 (10%) | 2 (5%) |
| Necrotic | 4 (5%) | 3 (8%) |
| Muscle Invasive | 1 (1%) | 0 (0%) |
| No Descriptor | 32 (41%) | 4 (11%) |
Rates of documentation of key TURBT operative steps across both cycles.
TURBT: Transurethral Resection of Bladder Tumour
| Measured Parameter | Cycle 1 Documented n (%) | Cycle 2 Documented n (%) | P-values |
| Number of Tumours | 78 (100%) | 37 (100%) | 1.00 |
| Tumour size | 36 (46%) | 33 (89%) | <0.05 |
| Tumour description/characteristics | 46 (59%) | 33 (89%) | 0.001 |
| Completeness of resection | 46 (59%) | 25 (68%) | 0.42 |
| Depth of resection | 28 (36%) | 33 (89%) | <0.05 |
| Administration of Chemotherapy | 16 (21%) | 20 (46%) | <0.05 |
| Perforation assessment | 17 (22%) | 25 (68%) | 0.001 |
| Pre-operative Examination Under Anaesthesia | 37 (47%) | 33 (89%) | <0.05 |
| Post-operative Examination Under Anaesthesia | 11 (14%) | 33 (89%) | <0.05 |